Results suggest that both rare and common DNA variations in PNPLA3 and SAMM50 may be correlated with NAFLD in this small population study, while common DNA variations in CHUK and ERLIN1, may have a protective interaction. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.